1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Combined Estrogen Alpha and Beta Receptor Expression Has a Prognostic Significance for Colorectal Cancer Patients
(
- Contribution to journal › Article
- 2021
-
Mark
Breast Cancer Biomarkers with Clinical Relevance Identified by Massively-parallel DNA and RNA Sequencing
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2020
-
Mark
Estrogen receptors and inflammation in colorectal cancer. Role in prognosis and therapeutic opportunities.
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2016
-
Mark
Estrogen Receptor Beta Selective Agonists as Agents to Treat Chemotherapeutic-Induced Neuropathic Pain
(
- Contribution to journal › Article
- 2014
-
Mark
Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study
(
- Contribution to journal › Article
-
Mark
Deficiency of ER beta and prostate tumorigenesis in FGF8b transgenic mice
(
- Contribution to journal › Article
- 2008
-
Mark
Haplotypes of the estrogen receptor beta gene and breast cancer risk
(
- Contribution to journal › Article
-
Mark
Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study
(
- Contribution to journal › Article
-
Mark
Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist
(
- Contribution to journal › Article
-
Mark
Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist
(
- Contribution to journal › Article